Quick answer: getting a Trulicity script in Australia
- Indication: Trulicity is approved for type 2 diabetes in adults; it is not approved for weight loss.
- Who can prescribe: Any Australian-registered doctor (GP or specialist). Telehealth is commonly available.
- PBS vs private: Eligible patients may access PBS pricing with criteria; otherwise a private script is required.
- Pharmacy access: Community pharmacies dispense weekly pens; supply can vary by location and dose strength.
- Alternatives: For weight loss queries, discuss Wegovy (semaglutide) or other medical weight management pathways.
Who can prescribe Trulicity (dulaglutide)?
In Australia, Trulicity can be prescribed by any registered medical practitioner. Most people start with their GP; others see an endocrinologist or a diabetes clinic. Many providers offer telehealth for ongoing management once treatment is established.
- GPs: most common first step for assessment and PBS eligibility checks
- Endocrinologists: complex diabetes, multiple medicines or complications
- Telehealth clinics: convenient for follow-up scripts if appropriate
Eligibility: PBS criteria vs private prescription
Access can occur via the Pharmaceutical Benefits Scheme (PBS) or on a private prescription. Your doctor confirms medical suitability and the appropriate route.
PBS pathway (for eligible type 2 diabetes)
- Trulicity is PBS-listed for adults with type 2 diabetes who meet defined criteria set by the PBS.
- The prescriber supplies the correct PBS item and, where required, streamlined authority details.
- You pay the standard PBS co-payment if approved; safety net rules apply as usual.
Private prescription
- Used when PBS criteria are not met or supply requires a private fill.
- Price varies by dose and pharmacy. See our cost guide for typical private pricing ranges.
What if you’re asking for weight loss?
Trulicity is not approved for weight loss in Australia. Off‑label requests are usually declined. If your primary goal is weight management, discuss approved GLP‑1 options and comprehensive care with your prescriber.
- Weight-loss specific brand: Wegovy (semaglutide) is approved for chronic weight management.
- Diabetes-first GLP‑1 with weight effects: Mounjaro (tirzepatide) and Ozempic (semaglutide) are approved for type 2 diabetes; weight change is a secondary outcome.
- Oral option for diabetes: Rybelsus (oral semaglutide) for type 2 diabetes where suitable.
How telehealth prescriptions work
- Book an assessment: provide history, current medicines, and recent blood tests (HbA1c, renal function, lipids).
- Clinical review: your doctor confirms indications, reviews PBS criteria and checks for contraindications.
- Script issued: an eRx token (electronic prescription) is sent to you by SMS or email.
- Pharmacy fill: present the token at your preferred community pharmacy; arrange delivery or pickup.
- Follow‑up: dose titration, side‑effect monitoring, and repeat labs as advised.
Pharmacy access, dosing and storage
Dispensing and availability
- Trulicity is dispensed by community pharmacies; some manage waitlists during tight supply.
- Ask about alternative strengths if your usual dose is out of stock and speak with your prescriber before any change.
Dose and administration
- Once‑weekly subcutaneous injection, same day each week.
- Common strengths in Australia include 0.75 mg and 1.5 mg pens; availability of higher doses may vary.
- Pharmacist training covers pen use, injection sites and disposal.
Storage
- Refrigerate at 2–8°C before use; do not freeze.
- If needed, pens can generally be kept at room temperature (up to 30°C) for a limited time; check the Consumer Medicine Information for exact limits.
Side effects and safety checks
Common effects include nausea, vomiting, diarrhoea, decreased appetite and injection‑site reactions, especially during dose changes. Serious but less common risks can include pancreatitis, gallbladder issues and dehydration‑related kidney effects. Hypoglycaemia risk increases when combined with insulin or certain diabetes tablets.
- Avoid if you have a personal/family history of medullary thyroid carcinoma or MEN 2, unless your specialist advises otherwise.
- Discuss pancreatitis history, significant GI disease, gallbladder disease, pregnancy/breastfeeding and renal function with your doctor.
- Read the full safety information and call for urgent care if you have severe abdominal pain, persistent vomiting or signs of dehydration.
More details: Trulicity Side Effects
How Trulicity compares to other GLP‑1 options
- Dulaglutide vs Semaglutide: weekly options with different evidence and dose ranges.
- Mounjaro vs Ozempic: dual‑agonist vs GLP‑1 only for diabetes management.
- Ozempic vs Wegovy: same molecule, different indications and dosing for diabetes vs weight loss.
See the broader landscape: GLP‑1 Australia Guide and Weight Loss Injections Australia.
Pricing: PBS co‑payment vs private costs
If you qualify for the PBS, you’ll pay the standard PBS co‑payment (and safety‑net rules may apply). Private scripts are charged at the pharmacy’s retail price, which varies by strength and location. Always ask your pharmacist for an up‑to‑date quote.
For current ranges and cost drivers, see: Trulicity Cost Australia
Frequently asked questions
Is Trulicity available through any pharmacy?
Yes, it’s a Schedule 4 prescription medicine and can be dispensed by community pharmacies. Availability depends on stock at your chosen pharmacy.
Do I need recent blood tests before starting?
Your doctor may request HbA1c, kidney function and other labs before and during treatment to guide safe use.
How quickly will I notice an effect?
Glycaemic effects are typically assessed over weeks to months. Your doctor will monitor HbA1c and self‑monitoring data to adjust your plan.
Can I switch from another GLP‑1 to Trulicity?
Possibly, but timing and dose need clinical oversight to reduce side‑effect risk. Don’t overlap medicines unless your prescriber advises it.
What if my pharmacy is out of stock?
Ask them to place you on a waitlist and check neighbouring pharmacies. Your prescriber can discuss bridging options or alternative therapies if appropriate.
Is there a once‑daily tablet alternative?
Rybelsus (oral semaglutide) is a daily tablet for type 2 diabetes in certain patients. Suitability depends on your clinical profile.
Get help with a Trulicity prescription
Complete the form and we’ll connect you with information on eligible prescribers, PBS checks and nearby pharmacies.
General information only. This page does not replace personalised medical advice. Always speak with your doctor or pharmacist.
Final takeaway
In Australia, Trulicity prescriptions are straightforward when you meet clinical and PBS criteria for type 2 diabetes. If you’re primarily exploring weight loss, discuss approved alternatives and a comprehensive plan with your prescriber. Telehealth and community pharmacies make access practical once therapy is established.